2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
31
Neoplasms
13
Stomach Neoplasms
11
Lung Neoplasms
11
Endometrial Neoplasms
11
Lymphatic Metastasis
7
Head and Neck Neoplasms
7
Carcinoma, Hepatocellular
7
Melanoma
6
Esophageal Neoplasms
6
Uterine Cervical Neoplasms
5
Rectal Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Ovarian Neoplasms
4
Brain Neoplasms
4
Vulvar Neoplasms
3
Sarcoma
3
Prostatic Neoplasms
3
Lymphedema
3
Colorectal Neoplasms
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Solitary Pulmonary Nodule
2
Skull Base Neoplasms
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Peritoneal Neoplasms
2
Osteosarcoma
2
Multiple Pulmonary Nodules
2
Interventions
Sorafenib
68
Bevacizumab
44
Oxaliplatin
25
Doxorubicin
22
Gemcitabine
21
Fluorouracil
21
Radiosurgery
20
Nivolumab
19
durvalumab
18
Radiofrequency Ablation
18
pembrolizumab
17
lenvatinib
17
Cisplatin
17
Capecitabine
17
atezolizumab
14
Leucovorin
14
Hepatectomy
14
Radiotherapy
12
tremelimumab
10
Irinotecan
10
Drug Therapy
10
Cyclophosphamide
10
Carboplatin
10
Blood Specimen Collection
10
Ipilimumab
9
regorafenib
8
Liver Transplantation
8
Everolimus
8
Cryosurgery
8
Chemotherapy, Adjuvant
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Indocyanine Green
×
Clear all
NCT05160740
2022-02-04
ICGMFITinPLC
Zhujiang Hospital
Phase NA
Unknown
348 enrolled